Trendlines Group says associated company ET View Medical (ETView) is in talks with a potential buyer for US$16 million ($21.58 million).
In a statement on Friday, the Israeli incubator of tech start-ups in the medical and agricultural fields said ETView will be delisted from the Tel Aviv Stock Exchange (TASE) should the deal follow through, as the sale is based on the structure of a reverse triangular merger.
Trendlines currently owns 26.46% of ETView. As at end March, the fair value of the group’s holdings in ETView was US$1.3 million.
The group expects to receive net proceeds of about US$3.3 million, and a gain from the sale of about US$2 million before taxes, should the proposed sale be concluded.
In February this year, Trendlines reported a loss of US$3.3 million for FY15.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
In a statement on Friday, the Israeli incubator of tech start-ups in the medical and agricultural fields said ETView will be delisted from the Tel Aviv Stock Exchange (TASE) should the deal follow through, as the sale is based on the structure of a reverse triangular merger.
Trendlines currently owns 26.46% of ETView. As at end March, the fair value of the group’s holdings in ETView was US$1.3 million.
The group expects to receive net proceeds of about US$3.3 million, and a gain from the sale of about US$2 million before taxes, should the proposed sale be concluded.
In February this year, Trendlines reported a loss of US$3.3 million for FY15.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
0 comments:
Post a Comment